Form 8-K - Current report:
SEC Accession No. 0001839882-24-030149
Filing Date
2024-09-23
Accepted
2024-09-23 07:08:50
Documents
102
Period of Report
2024-09-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp_8k-092324.htm   iXBRL 8-K 30344
2 PRESS RELEASE ex99-01.htm EX-99.01 22245
3 MANNITOL AS EUTECTIC FORMING AGENT FOR IMPROVED SUBLINGUAL DELIVERY OF CYCLOBENZ ex99-02.htm EX-99.02 40079
4 PHARMACOKINETIC PROPERTIES OF TNX-102 SL, A SUBLINGUAL FORMULATION OF CYCLOBENZA ex99-03.htm EX-99.03 44734
5 THE IMPORTANCE OF IN VITRO DISCRIMINATORY TESTS IN THE DEVELOPMENT OF A SUBLINGU ex99-04.htm EX-99.04 8231
9 GRAPHIC ex9902_001.jpg GRAPHIC 238459
10 GRAPHIC ex9902_002.jpg GRAPHIC 120128
11 GRAPHIC ex9902_003.jpg GRAPHIC 516139
12 GRAPHIC ex9902_004.jpg GRAPHIC 366231
13 GRAPHIC ex9902_005.jpg GRAPHIC 352265
14 GRAPHIC ex9902_006.jpg GRAPHIC 246866
15 GRAPHIC ex9902_007.jpg GRAPHIC 388798
16 GRAPHIC ex9902_008.jpg GRAPHIC 410726
17 GRAPHIC ex9902_009.jpg GRAPHIC 257332
18 GRAPHIC ex9902_010.jpg GRAPHIC 346394
19 GRAPHIC ex9902_011.jpg GRAPHIC 462250
20 GRAPHIC ex9902_012.jpg GRAPHIC 257326
21 GRAPHIC ex9902_013.jpg GRAPHIC 227363
22 GRAPHIC ex9902_014.jpg GRAPHIC 310771
23 GRAPHIC ex9902_015.jpg GRAPHIC 253726
24 GRAPHIC ex9902_016.jpg GRAPHIC 257169
25 GRAPHIC ex9902_017.jpg GRAPHIC 233553
26 GRAPHIC ex9902_018.jpg GRAPHIC 295129
27 GRAPHIC ex9902_019.jpg GRAPHIC 199654
28 GRAPHIC ex9902_020.jpg GRAPHIC 331513
29 GRAPHIC ex9902_021.jpg GRAPHIC 298628
30 GRAPHIC ex9902_022.jpg GRAPHIC 381144
31 GRAPHIC ex9902_023.jpg GRAPHIC 240826
32 GRAPHIC ex9902_024.jpg GRAPHIC 217134
33 GRAPHIC ex9902_025.jpg GRAPHIC 226682
34 GRAPHIC ex9902_026.jpg GRAPHIC 455128
35 GRAPHIC ex9902_027.jpg GRAPHIC 304542
36 GRAPHIC ex9902_028.jpg GRAPHIC 226632
37 GRAPHIC ex9902_029.jpg GRAPHIC 303739
38 GRAPHIC ex9902_030.jpg GRAPHIC 272177
39 GRAPHIC ex9902_031.jpg GRAPHIC 229642
40 GRAPHIC ex9902_032.jpg GRAPHIC 258535
41 GRAPHIC ex9902_033.jpg GRAPHIC 352544
42 GRAPHIC ex9902_034.jpg GRAPHIC 443666
43 GRAPHIC ex9902_035.jpg GRAPHIC 306570
44 GRAPHIC ex9902_036.jpg GRAPHIC 245107
45 GRAPHIC ex9902_037.jpg GRAPHIC 222726
46 GRAPHIC ex9902_038.jpg GRAPHIC 307483
47 GRAPHIC ex9902_039.jpg GRAPHIC 402325
48 GRAPHIC ex9902_040.jpg GRAPHIC 281120
49 GRAPHIC ex9902_041.jpg GRAPHIC 417217
50 GRAPHIC ex9902_042.jpg GRAPHIC 444411
51 GRAPHIC ex9902_043.jpg GRAPHIC 256054
52 GRAPHIC ex9902_044.jpg GRAPHIC 244404
53 GRAPHIC ex9902_045.jpg GRAPHIC 149322
54 GRAPHIC ex9902_046.jpg GRAPHIC 103098
55 GRAPHIC ex9903_001.jpg GRAPHIC 692744
56 GRAPHIC ex9903_002.jpg GRAPHIC 614765
57 GRAPHIC ex9903_003.jpg GRAPHIC 325714
58 GRAPHIC ex9903_004.jpg GRAPHIC 302578
59 GRAPHIC ex9903_005.jpg GRAPHIC 389398
60 GRAPHIC ex9903_006.jpg GRAPHIC 507623
61 GRAPHIC ex9903_007.jpg GRAPHIC 488313
62 GRAPHIC ex9903_008.jpg GRAPHIC 441038
63 GRAPHIC ex9903_009.jpg GRAPHIC 398022
64 GRAPHIC ex9903_010.jpg GRAPHIC 376486
65 GRAPHIC ex9903_011.jpg GRAPHIC 385108
66 GRAPHIC ex9903_012.jpg GRAPHIC 380161
67 GRAPHIC ex9903_013.jpg GRAPHIC 356365
68 GRAPHIC ex9903_014.jpg GRAPHIC 350912
69 GRAPHIC ex9903_015.jpg GRAPHIC 382159
70 GRAPHIC ex9903_016.jpg GRAPHIC 422259
71 GRAPHIC ex9903_017.jpg GRAPHIC 512409
72 GRAPHIC ex9903_018.jpg GRAPHIC 441829
73 GRAPHIC ex9903_019.jpg GRAPHIC 351413
74 GRAPHIC ex9903_020.jpg GRAPHIC 388128
75 GRAPHIC ex9903_021.jpg GRAPHIC 402025
76 GRAPHIC ex9903_022.jpg GRAPHIC 311917
77 GRAPHIC ex9903_023.jpg GRAPHIC 493078
78 GRAPHIC ex9903_024.jpg GRAPHIC 375295
79 GRAPHIC ex9903_025.jpg GRAPHIC 431027
80 GRAPHIC ex9903_026.jpg GRAPHIC 538339
81 GRAPHIC ex9903_027.jpg GRAPHIC 472014
82 GRAPHIC ex9903_028.jpg GRAPHIC 522864
83 GRAPHIC ex9903_029.jpg GRAPHIC 435178
84 GRAPHIC ex9903_030.jpg GRAPHIC 534405
85 GRAPHIC ex9903_031.jpg GRAPHIC 497149
86 GRAPHIC ex9903_032.jpg GRAPHIC 524049
87 GRAPHIC ex9903_033.jpg GRAPHIC 513967
88 GRAPHIC ex9903_034.jpg GRAPHIC 280077
89 GRAPHIC ex9903_035.jpg GRAPHIC 487020
90 GRAPHIC ex9903_036.jpg GRAPHIC 420718
91 GRAPHIC ex9903_037.jpg GRAPHIC 506536
92 GRAPHIC ex9903_038.jpg GRAPHIC 643620
93 GRAPHIC ex9904_001.jpg GRAPHIC 718868
  Complete submission text file 0001839882-24-030149.txt   43444371

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tnxp-20240923.xsd EX-101.SCH 3024
7 XBRL LABEL FILE tnxp-20240923_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE tnxp-20240923_pre.xml EX-101.PRE 22365
104 EXTRACTED XBRL INSTANCE DOCUMENT tnxp_8k-092324_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 241314619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)